WO2007066130A3 - Composition veterinaire - Google Patents
Composition veterinaire Download PDFInfo
- Publication number
- WO2007066130A3 WO2007066130A3 PCT/GB2006/004597 GB2006004597W WO2007066130A3 WO 2007066130 A3 WO2007066130 A3 WO 2007066130A3 GB 2006004597 W GB2006004597 W GB 2006004597W WO 2007066130 A3 WO2007066130 A3 WO 2007066130A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- endoparasites
- veterinary composition
- composition against
- against endoparasites
- benzimidiazole
- Prior art date
Links
- 244000079386 endoparasite Species 0.000 title abstract 3
- 241000242711 Fasciola hepatica Species 0.000 abstract 2
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 abstract 1
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 abstract 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 abstract 1
- 241000243974 Haemonchus contortus Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- JMPFSEBWVLAJKM-UHFFFAOYSA-N N-{5-chloro-4-[(4-chlorophenyl)(cyano)methyl]-2-methylphenyl}-2-hydroxy-3,5-diiodobenzamide Chemical compound ClC=1C=C(NC(=O)C=2C(=C(I)C=C(I)C=2)O)C(C)=CC=1C(C#N)C1=CC=C(Cl)C=C1 JMPFSEBWVLAJKM-UHFFFAOYSA-N 0.000 abstract 1
- 241000543819 Oestrus ovis Species 0.000 abstract 1
- 229950004178 closantel Drugs 0.000 abstract 1
- 208000006275 fascioliasis Diseases 0.000 abstract 1
- 229960002418 ivermectin Drugs 0.000 abstract 1
- 150000002596 lactones Chemical class 0.000 abstract 1
- WKEDVNSFRWHDNR-UHFFFAOYSA-N salicylanilide Chemical compound OC1=CC=CC=C1C(=O)NC1=CC=CC=C1 WKEDVNSFRWHDNR-UHFFFAOYSA-N 0.000 abstract 1
- 229950000975 salicylanilide Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La présente invention concerne l'utilisation d'un inhibiteur de la reproduction comprenant un salicylanilide pour la fabrication d'un médicament vétérinaire destiné à l'inhibition de la capacité reproductrice des endoparasites en développement et de la forme mature résultante infectant un hôte animal.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0525093.1 | 2005-12-09 | ||
GBGB0525093.1A GB0525093D0 (en) | 2005-12-09 | 2005-12-09 | Veterinary composition |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007066130A2 WO2007066130A2 (fr) | 2007-06-14 |
WO2007066130A3 true WO2007066130A3 (fr) | 2007-08-16 |
Family
ID=35735821
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2006/004597 WO2007066130A2 (fr) | 2005-12-09 | 2006-12-08 | Composition veterinaire |
Country Status (4)
Country | Link |
---|---|
AR (1) | AR058298A1 (fr) |
GB (2) | GB0525093D0 (fr) |
PE (1) | PE20070809A1 (fr) |
WO (1) | WO2007066130A2 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2991173B1 (fr) | 2012-06-04 | 2015-11-06 | Virbac | Composition veterinaire a administration cutanee a base d'oxyclozanide |
EA022327B1 (ru) * | 2013-01-04 | 2015-12-30 | Общество С Ограниченной Ответственностью "Рубикон" | Инъекционное ветеринарное средство в форме раствора для борьбы с полиинвазиями животного и способ его получения |
SG11201701928RA (en) | 2014-09-12 | 2017-04-27 | Antibiotx Aps | Antibacterial use of halogenated salicylanilides |
GB201509326D0 (en) | 2015-05-29 | 2015-07-15 | Antibio Tx Aps | Novel use |
GB201604484D0 (en) | 2016-03-16 | 2016-04-27 | Antibiotx Aps And Københavns Uni University Of Copenhagen | Topical antibacterial compositions |
EP3403652A1 (fr) | 2017-05-18 | 2018-11-21 | Veterinärmedizinische Universität Wien | Prévention et traitement de troubles associés au facteur de croissance 23 des fibroblastes (fgf23) incluant la maladie rénale chronique (ckd) |
IT201800004309A1 (it) * | 2018-04-09 | 2019-10-09 | Trattamenti topici per la miasi oculare | |
US11419834B2 (en) | 2019-02-25 | 2022-08-23 | Rhode Island Hospital | Methods for treating diseases or infections caused by or associated with H. pylori using a halogenated salicylanilide |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994028887A1 (fr) * | 1993-06-15 | 1994-12-22 | The Australian National University | Compositions anthelmintiques synergiques |
WO2001060380A1 (fr) * | 2000-02-16 | 2001-08-23 | Phoenix Scientific, Inc. | Formulation antiparasitaire et procede de fabrication de cette formulation |
-
2005
- 2005-12-09 GB GBGB0525093.1A patent/GB0525093D0/en not_active Ceased
-
2006
- 2006-12-08 GB GBGB0624565.8A patent/GB0624565D0/en not_active Ceased
- 2006-12-08 WO PCT/GB2006/004597 patent/WO2007066130A2/fr active Application Filing
- 2006-12-11 PE PE2006001584A patent/PE20070809A1/es not_active Application Discontinuation
- 2006-12-11 AR ARP060105435A patent/AR058298A1/es unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994028887A1 (fr) * | 1993-06-15 | 1994-12-22 | The Australian National University | Compositions anthelmintiques synergiques |
WO2001060380A1 (fr) * | 2000-02-16 | 2001-08-23 | Phoenix Scientific, Inc. | Formulation antiparasitaire et procede de fabrication de cette formulation |
Non-Patent Citations (8)
Title |
---|
CAMPBELL A J ET AL: "A comparison of the activity of uncouplers of oxidative phosphorylation against the common liver fluke Fasciola hepatica.", MOLECULAR AND BIOCHEMICAL PARASITOLOGY DEC 1981, vol. 4, no. 3-4, December 1981 (1981-12-01), pages 139 - 147, XP008075946, ISSN: 0166-6851 * |
CRUTHERS L R ET AL: "Efficacy of a tribromosalan and parbendazole composition against adult Fasciola hepatica in sheep.", RESEARCH IN VETERINARY SCIENCE JAN 1981, vol. 30, no. 1, January 1981 (1981-01-01), pages 122 - 123, XP008075915, ISSN: 0034-5288 * |
FAIRWEATHER I ET AL: "Fasciolicides: efficacy, actions, resistance and its management.", VETERINARY JOURNAL (LONDON, ENGLAND : 1997) SEP 1999, vol. 158, no. 2, September 1999 (1999-09-01), pages 81 - 112, XP002423819, ISSN: 1090-0233 * |
HANNA ET AL: "The effect of a parenteral ivermectin/closantel injection on the growth and reproductive development of early immature Fasciola hepatica in cattle", VETERINARY PARASITOLOGY, ELSEVIER SCIENCE, AMSTERDAM, NL, vol. 142, no. 1-2, 30 November 2006 (2006-11-30), pages 78 - 90, XP005714804, ISSN: 0304-4017 * |
MARTIN R J: "Modes of action of anthelmintic drugs.", VETERINARY JOURNAL (LONDON, ENGLAND : 1997) JUL 1997, vol. 154, no. 1, July 1997 (1997-07-01), pages 11 - 34, XP004762615, ISSN: 1090-0233 * |
MOLL L ET AL: "Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The netherlands.", VETERINARY PARASITOLOGY 24 JUL 2000, vol. 91, no. 1-2, 24 July 2000 (2000-07-24), pages 153 - 158, XP008075942, ISSN: 0304-4017 * |
STEVENSON C R ET AL: "THE EFFICACY OF FORMULATIONS OF TRICLABENDAZOLE AND IVERMECTIN IN COMBINATION AGAINST LIVER FLUKE (FASCIOLA HEPATICA) AND GASTRO-INTESTINAL NEMATODES IN CATTLE AND SHEEP AND SUCKING LICE SPECIES IN CATTLE", AUSTRALIAN VETERINARY JOURNAL, AUSTRALIAN VETERINARY ASSOCIATION, BRUNSWICK, AU, vol. 80, no. 11, November 2002 (2002-11-01), pages 698 - 701, XP008075909, ISSN: 0005-0423 * |
SWAN G E ET AL: "EFFICACY OF IVERMECTIN AGAINST INTERNAL PARASITES OF SHEEP", JOURNAL OF THE SOUTH AFRICAN VETERINARY MEDICAL ASSOCIATION, PRETORIA,, SA, vol. 55, no. 4, December 1984 (1984-12-01), pages 165 - 169, XP008075921, ISSN: 0038-2809 * |
Also Published As
Publication number | Publication date |
---|---|
GB0624565D0 (en) | 2007-01-17 |
PE20070809A1 (es) | 2007-08-27 |
GB0525093D0 (en) | 2006-01-18 |
AR058298A1 (es) | 2008-01-30 |
WO2007066130A2 (fr) | 2007-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007066130A3 (fr) | Composition veterinaire | |
BRPI0607762B8 (pt) | análogos de glp-1, composição farmacêutica contendo os mesmos e uso de um composto | |
ECSP109852A (es) | Uso de homo y copolímeros para la estabilización de formulaciones de principios activos | |
CL2008002430A1 (es) | Compuestos derivados de bencenosulfonamida, inhibidores de catepsina c; composicion farmaceutica que los comprende; y su uso para el tratamiento de la epoc. | |
EA200900392A1 (ru) | Комбинированное лечение сахарного диабета | |
ECSP077299A (es) | Nuevas composiciones farmacéuticas que comprenden ácido 4-(4-(3-(4-cloro-3-trifluorometil-fenil)-ureido)-3-fluoro-fenoxi)-piridin-2-carboxílico para el tratamiento de trastornos hiperproliferativos | |
WO2007034196A3 (fr) | Agents d'imagerie | |
WO2007100776A3 (fr) | Compositions antimicrobiennes et méthodes pour verrouiller des cathéters | |
BRPI0806531A2 (pt) | Composto, composição farmacêutica, agente terapêutico, e, uso do composto. | |
AR057456A1 (es) | Inhibidores de la proteasa ns3 del vhc | |
CL2007002971A1 (es) | Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras. | |
AR059203A1 (es) | Composiciones para uso vaginal | |
CL2007003557A1 (es) | Compuestos derivados de heterociclos de nitrogeno, inhibidores de la actividad sobre b-raf; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer. | |
AR109263A2 (es) | Composición que comprende moxidectina | |
CL2007002970A1 (es) | Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras. | |
CY1117174T1 (el) | ΧΡΗΣΗ 24-norUDCA ΓΙΑ ΤΗΝ ΑΓΩΓΗ ΧΟΛΟΣΤΑΤΙΚΩΝ ΝΟΣΗΜΑΤΩΝ ΤΟΥ ΗΠΑΤΟΣ | |
WO2010047592A3 (fr) | Mélange conservateur et ses applications | |
CL2004000710A1 (es) | Composicion antimicrobiana y antiparasitaria formada por un antibiotico derivado del cloranfenicol o tianfenicol, un endectocida y por lo menos un vehiculo aceptable, y su uso para tratar enfermedades respiratorias y parasitarias de los bovinos. | |
CR9364A (es) | Agentes endoparasiticidas | |
ATE409719T1 (de) | Verfahren zur herstellung fester treibmittelpräparationen | |
AR056749A1 (es) | Formulaciones de dosificacion oral de ibuprofeno organolepticamente aceptables metodos para su preparacion y uso | |
SV2008003139A (es) | Profarmacos de penem | |
BRPI0720114A8 (pt) | Uso de um antagonista beta-adrenérgico e antagonista ou agonista parcial de 5-ht1a combinados, método para tratar caquexia, e, antagonista beta-adrenérgico e antagonista ou agonista parcial de 5-ht1a combinados | |
CR9074A (es) | Agente para la profilaxis o tratamiento del sindrome metabolico | |
DK1220676T3 (da) | Forebyggelse af colorektal cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06820466 Country of ref document: EP Kind code of ref document: A2 |